2024-03-26T16:45:44-05:00 2023-06-30 430765316 RUBINBROWN LLP 7676 FORSYTH BLVD SUITE 2100 SAINT LOUIS MO 63105 990 2022-07-01 131632524 AMERICAN LUNG ASSOCIATION AMER 2177875864 55 W WACKER DRIVE 1150 CHICAGO IL 60601 LAURA SCOTT CFO 2177875864 2024-03-25 1 LAURA SCOTT 999009999 1 KIMBERLY A RYAN P00829977 3142903300 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z HAROLD WIMMER 55 W WACKER DRIVE 1150 CHICAGO IL 60601 122295456 0 X WWW.LUNG.ORG X 1918 ME THE MISSION OF THE ALA IS TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. 16 16 558 76396 0 0 112291164 100309671 2513033 2320005 9862711 3245323 4726028 2714063 129392936 108589062 13235010 13632659 0 0 41926003 46337379 446755 378000 12160691 46318937 52613030 101926705 112961068 27466231 -4372006 215049116 221359539 49385591 46960908 165663525 174398631 X THE AMERICAN LUNG ASSOCIATION'S MISSION IS TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. WE DO THIS THROUGH EDUCATION, ADVOCACY, AND RESEARCH. 0 0 56291897 2611452 LUNG CANCER, ASTHMA, LUNG DISEASE AND TOBACCO CONTROL: LUNG DISEASE, INCLUDING COPD AND LUNG CANCER, IS A LEADING CAUSE OF DEATH IN THE U.S. AND LUNG CANCER IS THE LEADING CAUSE OF CANCER DEATH. THE COVID-19 PANDEMIC, IN ITS FOURTH YEAR, CONTINUES TO BE A PRIORITY FOR THE COUNTRY AND FOR THE AMERICAN LUNG ASSOCIATION. THE LUNG ASSOCIATION WORKS EVERY DAY ACROSS THE U.S. TO RAISE AWARENESS FOR THE NEED TO PRIORITIZE LUNG DISEASE PREVENTION AND TREATMENT, PROTECT OUR AIR, REDUCE TOBACCO USE, PROVIDE SUPPORT FOR PEOPLE LIVING WITH LUNG DISEASE AND THEIR CAREGIVERS, AND RAISE FUNDS FOR RESEARCH TO BENEFIT EVERYONE'S LUNGS. AS THE COVID-19 PANDEMIC EVOLVED IN THIS COUNTRY, OUR RESPONSE ADAPTED AS WELL. WE LEVERAGED OUR MYRIAD COMMUNICATIONS VEHICLES, PR EFFORTS AND SOCIAL MEDIA TO HELP THE PUBLIC UNDERSTAND WHAT THE ANNOUNCED EMERGENCY'S END MEANT TO THEM AND URGED THEM TO KEEP UP WITH VACCINATIONS. OUR COVID-19 ACTION INITIATIVE, LAUNCHED IN THE FIRST YEAR OF THE PANDEMIC, CONTINUED BECAUSE THE DISEASE WAS FAR FROM GONE, AND PREVENTING FUTURE PANDEMICS LIKE COVID-19 IS ONE OF ITS PRIMARY GOALS. THE INITIATIVE HAS BEEN AN ONGOING CATALYST FOR NEW COVID ADVOCACY, OUTREACH AND THE COVID-19 AND OUR RESPIRATORY VIRUS RESEARCH AWARD WHICH PROVIDES FUNDING OF $100,000 A YEAR FOR TWO YEARS. OUR LUNGCAST PODCAST SERIES CONTINUED TO PROVIDE HEALTHCARE PROFESSIONALS WITH THE LATEST SCIENCE IN COVID-19, AND OTHER LUNG TOPICS AND INCLUDING SESSIONS ON COPD, LUNG CANCER SCREENING, HEALTH IMPACTS OF AIR POLLUTION AND MORE. THIS YEAR WE ALSO MADE PAST SESSIONS AVAILABLE ON OUR YOUTUBE CHANNEL, CREATING A VITAL AND GROWING LIBRARY FOR HEALTHCARE PROFESSIONALS.AS THE PROBLEM OF "LONG COVID" CONTINUED TO GROW, OUR ONLINE SUPPORT COMMUNITY CALLED LIVING WITH LONG COVID LAUNCHED LAST YEAR, EXPANDED AND KEPT PACE. THIS COMMUNITY ALLOWS THOSE FACING LONG COVID SYMPTOMS AND THEIR LOVED ONES TO CONNECT WITH OTHER PEOPLE IN THEIR SHOES FOR PEER-TO-PEER SUPPORT. IT JOINS OUR TEN OTHER ONLINE SUPPORT COMMUNITIES. THE FULL LIST IS AVAILABLE AT WWW.LUNG.ORG/COMMUNITY. OUR BETTER BREATHERS CLUBS ALSO CONTINUED TO WELCOME MORE AND MORE PEOPLE WITH LONG COVID SYMPTOMS. TO INCREASE ACCESS TO IMPORTANT HEALTH EDUCATION, WE UNVEILED IMPORTANT NEWS ENHANCEMENT TO OUR WEBSITE LUNG.ORG. THE ENHANCEMENTS INCLUDED ADDING AN "ACCESSIBILITY" BUTTON ON LUNG.ORG, WHICH GIVES USERS A MENU OF OPTIONS THAT ALLOWS THEM TO ENABLE SEVERAL ACCESSIBILITY FEATURES, SUCH AS DYSLEXIA-FRIENDLY FONT OPTIONS, CONTRAST ADJUSTMENTS, TEXT SIZE AND SPACING MODIFICATIONS, AND THE ABILITY TO PAUSE ANIMATIONS. IN ADDITION TO COVID-19, WE CONTINUED TO FOCUS ON ALL LUNG DISEASES, INCLUDING LUNG CANCER. WE CONTINUED OUR FOCUS ON REDUCING LUNG CANCER THROUGH OUR ONGOING LUNG FORCE INITIATIVE WHICH RAISES AWARENESS, LUNG CANCER RESEARCH FUNDING, AND PROVIDES EDUCATION AND SUPPORT TO LUNG CANCER PATIENTS AND CAREGIVERS. IN JUNE 2022, WE MARKED THE MILESTONE OF ONE MILLION LUNG CANCER SCREENING ELIGIBILITY QUIZ COMPLETIONS FOR THE SAVED BY THE SCAN CAMPAIGN. SINCE WE LAUNCHED SAVED BY THE SCAN IN 2017 IN PARTNERSHIP WITH THE AD COUNCIL, LUNG CANCER SCREENING RATES AMONG THOSE ELIGIBLE HAVE INCREASED BY MORE THAN 170%. IN NOVEMBER 2022, WE OBSERVED LUNG CANCER AWARENESS MONTH BY RELEASING OUR ANNUAL "STATE OF LUNG CANCER" REPORT WHICH SHOWS THE TOLL LUNG CANCER TAKES ON EACH STATE IN THE COUNTRY. THIS REPORT REVEALED THAT STATES MUST DO MORE TO PROTECT THEIR RESIDENTS FROM LUNG CANCER. FOR THE THIRD CONSECUTIVE YEAR, THE "STATE OF LUNG CANCER" REPORT ALSO EXPLORED THE LUNG CANCER BURDEN AMONG RACIAL AND ETHNIC GROUPS AT THE NATIONAL AND STATE LEVELS. RADON EXPOSURE IS THE SECOND LEADING RISK FACTOR FOR LUNG CANCER. DURING JANUARY, RADON ACTION MONTH, AND THROUGHOUT THE YEAR, WE ENCOURAGED EVERYONE TO TEST THEIR HOMES FOR RADON AND SEEK RADON MITIGATION IF NECESSARY. THE LUNG ASSOCIATION PLAYED A LEADERSHIP ROLE IN DEVELOPING AND RELEASING THE FIVE-YEAR NATIONAL RADON ACTION PLAN. WE ALSO CONTINUED TO OFFER OUR FREE RADON BASICS ONLINE COURSE, APPROPRIATE FOR ANYONE WHO WANTS TO LEARN MORE ABOUT RADON AND ABOUT HOW TO TEST FOR IT AND FIX PROBLEMS. IN MARCH, WE HELD OUR EIGHTH ANNUAL LUNG FORCE ADVOCACY DAY. LUNG FORCE HEROES - THOSE PERSONALLY AFFECTED BY LUNG CANCER - CAME TOGETHER FROM ACROSS THE COUNTRY IN WASHINGTON, DC TO MEET WITH THEIR MEMBERS OF CONGRESS ABOUT THE URGENT NEED TO ADDRESS LUNG CANCER. THEY ASKED CONGRESS TO SUPPORT $51 BILLION IN RESEARCH FUNDING FOR THE NATIONAL INSTITUTES OF HEALTH, SUPPORT $11.6 BILLION IN FUNDING FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO REBUILD HEALTHIER COMMUNITIES AND PROTECT OUR NATION'S HEALTH FROM DISEASE, INCLUDING LUNG CANCER AND TO SUPPORT AND PROTECT MEDICAID.ASTHMA MAKES BREATHING DIFFICULT FOR MILLIONS LIVING IN AMERICA, INCLUDING 5.5 MILLION CHILDREN. IN AUGUST 2022, WE LAUNCHED OUR PROMOTING ASTHMA FRIENDLY ENVIRONMENTS THROUGH PARTNERSHIPS AND COLLABORATIONS PROJECT WHICH USES PROVEN-EFFECTIVE STRATEGIES OUTLINED IN THE CDC EXHALE TECHNICAL PACKAGE TO IMPROVE ASTHMA CONTROL IN POPULATIONS. THIS RESOURCE JOINED OUR OTHER POPULAR ASTHMA TOOLS, INCLUDING THE INDOOR AIR QUALITY IN SCHOOLS GUIDE, OUR ASTHMA FRIENDLY SCHOOLS ONLINE MODULE, OPEN AIRWAYS FOR SCHOOLS AND MUCH MORE. WE ALSO PUBLISHED OUR VOICE OF THE PATIENT REPORT ABOUT ASTHMA IN CHILDHOOD, AS PART OF THE LITTLE AIRWAYS, BIG VOICES INITIATIVE.THIS PAST YEAR, A NEW INFECTIOUS LUNG DISEASE ROSE TO PROMINENCE RESPIRATORY SYNCYTIAL VIRUS OR RSV. WHEN RSV CASES ROSE DRAMATICALLY, WE TOOK ACTION TO HELP EDUCATE THE PUBLIC, CREATING AN ENTIRE LIBRARY OF TOOLS TO HELP THEM UNDERSTAND AND REDUCE ITS SPREAD. RSV IS A LEADING CAUSE OF HOSPITALIZATION AMONG INFANTS. TO HELP EXPECTANT AND NEW PARENTS BE PREPARED FOR THIS SEASONAL RESPIRATORY VIRUS, WE PARTNERED WITH SANOFI TO CREATE NEW WEB CONTENT INCLUDING AN "UNDERSTANDING RSV" ANIMATION IN ENGLISH AND SPANISH, A BLOG HIGHLIGHTING A PERSONAL STORY, A PSA, AND PATIENT AND PROVIDER VIDEOS. WE LAUNCHED A CUSTOM RSV LANDING PAGE AT LUNG.ORG/RSV. IN FEBRUARY 2023, WE WERE PROUD TO LAUNCH THE AMERICAN LUNG ASSOCIATION PATIENT & CAREGIVER NETWORK TO PROVIDE SUPPORT, EDUCATION AND ACCESS TO RESEARCH FOR THE 34 MILLION PEOPLE NATIONWIDE LIVING WITH LUNG DISEASE. THE PATIENT & CAREGIVER NETWORK IS AN ONLINE SUPPORT PROGRAM PROVIDING DIRECT ACCESS TO LUNG DISEASE MANAGEMENT TOOLS, EDUCATION, AND CONNECTION TO OTHER PATIENTS AND CAREGIVERS. WE ALSO CREATED A SERIES OF NEW LEARNING MODULES, INCLUDING COPD BASICS COURSE AND INFECTIOUS RESPIRATORY DISEASE BASICS COURSE.TOBACCO USE AND EXPOSURE TO SECONDHAND SMOKE CAUSES MORE THAN 480,000 DEATHS EVERY YEAR IN THE U.S. AND TRAGICALLY, EACH DAY THOUSANDS OF KIDS STILL PICK UP A TOBACCO PRODUCT FOR THE FIRST TIME. CREATING A TOBACCO-FREE FUTURE FOR AMERICA IS A CORE PART OF OUR MISSION. WE ARE FUNDING A ROBUST NUMBER OF RESEARCH PROJECTS TO HELP US BETTER UNDERSTAND TOBACCO USE, NICOTINE ADDICTION AND HOW TO REDUCE IT. AS THE NEW YEAR ROLLED AROUND, WE USED OUR EXTENSIVE MEDIA NETWORK TO ENCOURAGE SMOKERS TO "GO TOBACCO FREE IN 23." THROUGH OUR "TOBACCO-FREE '23" CAMPAIGN, WE WORKED TO INCREASE AWARENESS OF THE MANY RESOURCES, PROGRAMS AND SERVICES WE OFFER IN CREATING A TOBACCO-FREE FUTURE IN THE NEW YEAR, INCLUDING OUR LUNG HELPLINE AND TOBACCO QUITLINE (1-800-LUNGUSA), FREEDOM FROM SMOKING PROGRAM AND SUPPORT GROUPS.IN AN EFFORT TO FURTHER ADDRESS TOBACCO USE IN DIVERSE COMMUNITIES, WE RELEASED TWO NEW COMMUNITY TOOLKITS. THE AMERICAN LUNG ASSOCIATION'S ADDRESSING COMMERCIAL TOBACCO USE IN INDIGENOUS COMMUNITIES TOOLKIT EXAMINES ISSUES RELATED TO COMMERCIAL TOBACCO USE AND NICOTINE DEPENDENCE IN INDIGENOUS COMMUNITIES AND PROVIDES CULTURALLY COMPETENT STRATEGIES, TOOLS AND LESSONS LEARNED THAT CAN BE IMPLEMENTED BY PUBLIC HEALTH PROFESSIONALS SERVING DIVERSE INDIGENOUS COMMUNITIES. WE ALSO RELEASED THE ADDRESSING TOBACCO USE IN HISPANIC OR LATINO COMMUNITIES TOOLKIT WITH NUMEROUS COMMUNITY TOOLS AND RESOURCES IN ENGLISH AND SPANISH.AS PART OF OUR EDUCATION AND AWARENESS EFFORTS ON YOUTH VAPING, WE PROMOTED OUR "DOTHEVAPETALK" CAMPAIGN, PRODUCED IN COLLABORATION WITH THE AD COUNCIL. IN JUST TWO YEARS, OUR YOUTH VAPING PUBLIC AWARENESS CAMPAIGN HAS HELPED THOUSANDS OF PARENTS ACROSS THE COUNTRY TALK WITH THEIR CHILDREN ABOUT THE DANGERS OF VAPING. OVER 3.4M PEOPLE HAVE VISITED OUR "GET THE FACTS" PAGE. WE LAUNCHED NEW PUBLIC SERVICE ANNOUNCEMENTS AND EVEN RECEIVED DIGITAL MEDIA SUPPORT FROM NEW YORK TIMES BY FEATURING IT IN THEIR PODCASTS THIS YEAR. OUR 21ST ANNUAL "STATE OF TOBACCO CONTROL" REPORT, LAUNCHED IN JANUARY, REVEALING THE STATES WITH THE BEST AND WORST POLICIES TO PREVENT AND REDUCE TOBACCO USE AND FINDS DRAMATIC DIFFERENCES IN THE STRENGTH OF STATES' TOBACCO CONTROL LAWS. THE REPORT SERVES AS A BLUEPRINT FOR WHAT STATE AND FEDERAL LEADERS NEED TO DO TO ELIMINATE THE DEATH AND DISEASE CAUSED BY TOBACCO USE. 22116160 13632659 1025996 RESEARCH: FEW THINGS PROMISE TO IMPROVE PATIENTS' LIVES MORE THAN MEDICAL RESEARCH. FOR NEARLY 120 YEARS, THE AMERICAN LUNG ASSOCIATION HAS FOCUSED ON DRIVING EXCELLENCE AND INNOVATION THROUGH RESEARCH. THIS YEAR WE LAUNCHED THE AMERICAN LUNG ASSOCIATION RESEARCH INSTITUTE WHICH WILL FUND HIGH-IMPACT, LIFESAVING RESEARCH AND BRING TOGETHER THE BEST SCIENTIFIC MINDS TO ADDRESS CRITICAL LUNG HEALTH CHALLENGES. THE RESEARCH INSTITUTE WILL INCREASE OUR ANNUAL LUNG DISEASE RESEARCH INVESTMENT TO $25 MILLION BY 2030, EXPAND PARTNERSHIPS WITH GOVERNMENT AND COLLABORATION WITH INDUSTRY AND EMPOWER PROMISING SCIENTISTS TO ACCELERATE DISCOVERY AND INNOVATION. WE ALSO CONTINUED TO SUPPORT PROMISING RESEARCH IN ALL AREAS OF LUNG DISEASE, WITH THE HOPE OF ELIMINATING LUNG DISEASE AND IMPROVING THE LIVES OF THOSE LIVING WITH LUNG DISEASE. OUR RESEARCH PROGRAM INCLUDES OUR AWARDS AND GRANTS PROGRAM AND OUR EXPANDED AIRWAYS CLINICAL RESEARCH CENTERS NETWORK (ACRC), THE LARGEST NOT-FOR-PROFIT CLINICAL RESEARCH NETWORK DEDICATED TO ASTHMA AND COPD IN THE COUNTRY. THIS NETWORK CONDUCTS LARGE PATIENT-FOCUSED CLINICAL TRIALS LED BY SOME OF THE BEST INVESTIGATORS NATIONWIDE TO IMPROVE LUNG HEALTH. THIS YEAR, WE PUBLISHED NUMEROUS RESULTS FROM ACRC RELATED INVESTIGATIONS. ONE OF THESE, BY MARIO CASTRO, M.D. FOUND THE DRUG DUPILUMAB HELPED TO REDUCE EXACERBATIONS AND INCREASE LUNG FUNCTION IN PATIENTS WITH ASTHMA, REGARDLESS OF ALLERGIC ASTHMA STATUS. THIS IS IMPORTANT BECAUSE IT PROVIDES NEW GUIDELINES FOR ASTHMA THERAPY IN PATIENTS TO REDUCE THEIR SYMPTOMS AND IMPROVE THEIR QUALITY OF LIFE. THE LANDMARK AMERICAN LUNG ASSOCIATION LUNG HEALTH COHORT STUDY EXPANDED ENROLLMENT OF PARTICIPANTS. THIS IS THE FIRST-EVER LARGE-SCALE LUNG HEALTH STUDY THAT WILL TRACK THE LUNG HEALTH OF 4,000 YOUNG ADULTS STARTING AT AN AGE OF PEAK LUNG HEALTH. IN OCTOBER 2022, WE WERE PROUD TO ANNOUNCE WE WERE INVESTING AN ADDITIONAL $13.1 MILLION TO ACCELERATE LUNG HEALTH RESEARCH FOR 2022-2023. OUR ANNUAL ADVANCING RESEARCH PUBLICATION ILLUSTRATED OUR ONGOING RESEARCH INITIATIVES, FROM PATIENT STORIES TO SCIENTIFIC ARTICLES, AND RESEARCHER PROFILES AND CREATED A NEW WAY TO KEEP UP WITH OUR CUTTING-EDGE RESEARCH PROGRAM WITH OUR RESEARCH NEWS WEBSITE - HTTPS://WWW.LUNG.ORG/RESEARCH/ABOUT-OUR-RESEARCH/NEWS. DIVERSITY AND INCLUSION CONTINUE TO BE A KEY NEED IN THE WORLD OF RESEARCH, INCLUDING THE NEED TO IMPROVE ACCESS TO CLINICAL TRIALS. THE BLACK COMMUNITY IS DISPROPORTIONALLY IMPACTED BY LUNG CANCER AND UNDERREPRESENTED IN LUNG CANCER CLINICAL TRIALS. WE CONTINUED OUR PROGRAM AWARENESS, TRUST, AND ACTION - THE IMPORTANCE OF LUNG CANCER CLINICAL TRIALS TO REDUCE MISTRUST AND UNDER REPRESENTATION IN CLINICAL TRIALS, ESPECIALLY IN THE BLACK COMMUNITY. WE ALSO PLACED A FOCUS ON RESEARCH GRANTS THAT FOCUS ON EQUITY LIKE FUNDING TO SUPPORT THE HAROLD AMOS SCHOLAR PROGRAM. 18828433 873475 ADVOCACY AND ENVIRONMENTAL:EVERY YEAR, THE AMERICAN LUNG ASSOCIATION SUPPORTS POLICIES AND LEGISLATION THAT CAN LEAD TO BETTER LUNG HEALTH ACROSS THE NATION. THESE INCLUDE LAWS THAT PROTECT OUR CHILDREN FROM DEADLY AIR POLLUTION AND TOBACCO PRODUCTS, SUPPORT FUNDING FOR CRITICAL LUNG DISEASE RESEARCH AND HEALTH PROGRAMS AT THE FEDERAL LEVEL, PROVIDE AFFORDABLE, QUALITY HEALTHCARE FOR MORE PEOPLE, AND MUCH MORE. THIS YEAR WE FUNDED MULTIPLE RESEARCH PROJECTS THAT WILL BUILD OUR UNDERSTANDING OF THE MANY WAYS AIR POLLUTION IMPACTS OUR LUNGS. WE ALSO ADVOCATED FOR STRONGER POLICIES TO CLEAN UP AIR POLLUTION AND CURB CLIMATE CHANGE. WE WORKED TO EDUCATE THE PUBLIC, MEDIA AND OUR NATION'S LEADERS ABOUT THE HARMFUL EFFECT DIRTY AIR HAS ON HEALTH AND WHAT WE NEED TO DO TO CLEAN IT UP. WITHOUT QUESTION, OUR CHANGING CLIMATE IS HARMING HEALTH NOW. DROUGHT, WILDFIRES, HEAT, FLOODING, INCREASED AIR POLLUTION ARE JUST A FEW OF THE CHALLENGES WE ENCOUNTER FROM CLIMATE CHANGE. A REAL-LIFE EXAMPLE WAS THE WILDFIRES IN CANADA, WHICH BLANKETED MUCH OF THE U.S. IN LIFE-THREATENING PARTICLE POLLUTION DURING THE SUMMER OF 2023. WE WORKED HARD TO HELP THE PUBLIC UNDERSTAND THE RISK AND STAY SAFE BY SUPPLYING THE MEDIA WITH EXPERT INFORMATION AND PROVIDING ESSENTIAL TIPS AND INFORMATION AT LUNG.ORG/WILDFIRES.THIS PAST YEAR, WE SAW THE POSITIVE EFFECTS OF OUR CLEAN AIR ADVOCACY, SUCH AS WHEN CALIFORNIA VOTED TO REQUIRE 100% ZERO-EMISSION VEHICLE SALES BY 2035. IN OCTOBER 2022, EPA ANNOUNCED NEARLY $1 BILLION IN AWARDS FOR SCHOOL DISTRICTS TO PURCHASE CLEAN SCHOOL BUSES. WE RAN A VIGOROUS ADVOCACY CAMPAIGN IN SUPPORT OF CONGRESS PASSING INVESTMENTS IN ELECTRIC SCHOOL BUSES. THIS IS A MAJOR STEP FORWARD FOR HEALTH, BOTH FOR KIDS WHO RIDE BUSES AND SCHOOL COMMUNITIES AND NEIGHBORHOODS WHO ARE EXPOSED TO DANGEROUS EMISSIONS FROM DIESEL BUSES. IT'S ALSO A VICTORY FOR HEALTH EQUITY, WITH 99% OF THE FUNDS GOING TO DISTRICTS SERVING LOW-INCOME, RURAL OR TRIBAL STUDENTS.THE PAST YEAR SAW MANY SIGNIFICANT DEVELOPMENTS IN TERMS OF OUR TOBACCO ADVOCACY, SUCH AS WHEN FDA CLOSED THE "PUFF BAR LOOPHOLE" WHICH GAVE A PASS TO PRODUCTS CONTAINING ARTIFICIAL NICOTINE. AND WHEN A COURT ORDER WAS ISSUED THAT REQUIRED TOBACCO COMPANIES TO POST SIGNS ABOUT HEALTH RISKS OF SMOKING AT 200,000 STORES ACROSS U.S.WE CONTINUED OUR FOCUS ON REDUCING TAILPIPE POLLUTION, WHICH DRIVES AIR POLLUTION AND CLIMATE CHANGE WITH A SERIES OF REPORTS. IN OCTOBER 22, WE RELEASED "DELIVERING CLEAN AIR: HEALTH BENEFITS OF ZERO-EMISSION TRUCKS AND ELECTRICITY" SHOWING A MOVE TO ZERO-EMISSION TRUCKS COULD SAVE MORE THAN 66,000 LIVES, RESULT IN $735 BILLION IN PUBLIC HEALTH BENEFITS OVER THE NEXT 30 YEARS AND HELP CREATE A MORE EQUITABLE FUTURE. IN JUNE OF 2023 OUR REPORT "DRIVING TO CLEAN AIR: HEALTH BENEFITS OF ZERO-EMISSION CARS AND ELECTRICITY," FURTHER SHOWED THAT A WIDESPREAD TRANSITION TO ZERO-EMISSION PASSENGER VEHICLES AND ELECTRICITY WOULD DRAMATICALLY IMPROVE HEALTH AND SAVE LIVES. IN SEPTEMBER 2022, WE RELEASED A NEW REPORT "HEALTH IMPACTS OF COMBUSTION IN HOMES," EXPLORED THE HEALTH AND ENVIRONMENTAL IMPACTS OF INDOOR COMBUSTION AND THE LITERATURE ON THE NUMBER AND TYPE OF APPLIANCES IN U.S. HOMES, THEIR EMISSIONS, AND IMPACTS ON HEALTH AND THE INDOOR AND OUTDOOR ENVIRONMENT. TWO THIRDS OF U.S. HOUSEHOLDS BURN FUEL IN THEIR HOMES, WHICH PRODUCES EMISSIONS THAT ARE HARMFUL TO HUMAN HEALTH AND THE ENVIRONMENT. IN APRIL, WE RELEASED OUR ANNUAL "STATE OF THE AIR" REPORT, WHICH REVEALED GROWING DISPARITIES IN EXPOSURE TO AIR POLLUTION. THIS 24TH ANNUAL REPORT ALSO FINDS THAT 1 IN 3 PEOPLE LIVING IN THE U.S. ARE EXPOSED TO UNHEALTHY LEVELS OF AIR POLLUTION. THE REPORT FINDS THAT PEOPLE OF COLOR ARE SIGNIFICANTLY MORE LIKELY TO BREATHE POLLUTED AIR THAN WHITE PEOPLE. AS THE NATION WORKS TO ADDRESS CLIMATE CHANGE AND CONTINUE REDUCING AIR POLLUTION, WE MUST PRIORITIZE THE HEALTH OF DISPROPORTIONATELY BURDENED COMMUNITIES. QUALITY AND AFFORDABLE HEALTHCARE ACCESS IS CRUCIAL TO ALL AMERICANS, ESPECIALLY LUNG DISEASE PATIENTS, AND OUR ADVOCACY TEAM WORKED TO PROTECT ACCESS TO HEALTHCARE. WE CELEBRATED AN IMPORTANT VICTORY, WITH THE PASSAGE OF THE INFLATION REDUCTION ACT WHICH HAS PROVISIONS TO PROTECT HEALTHCARE FOR MILLIONS. WHEN HEALTHCARE ENROLLMENT OPENED AT HEALTHCARE.GOV, WE ROLLED OUT A SERIES OF UPDATED TOOLS TO HELP PEOPLE UNDERSTAND THEIR CHOICES AND THE ENROLLMENT PROCESS. 97236490 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 512 0 558 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 16 16 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MS NH NJ NM NY NC ND OH OK OR PA RI SC TN VA WA WV WI X X LAURA SCOTT CFO 2177875864 3000 KELLY LANE SPRINGFIELD IL 62711 CHERYL A CALHOUN CPA MBA CHAIR 2.00 X X 0 0 0 MICHAEL V CARSTENS SECRETARY / TREASURER 2.00 X X 0 0 0 SUMITA B KHATRI MD MS CHAIR ELECT, DIRECTOR (THRU 3/23) 2.00 X X 0 0 0 STEPHEN R O'KANE PAST CHAIR 2.00 X X 0 0 0 JOHNNY A SMITH JR MA VICE CHAIR 2.00 X X 0 0 0 FELIX AGUILAR MD MPH DIRECTOR (THRU 5/23) 2.00 X 0 0 0 RABIH I BECHARA MD FCCP DIRECTOR 2.00 X 0 0 0 ANNE E DIXON MD DIRECTOR 2.00 X 0 0 0 AFIF EL-HASAN MD DIRECTOR 2.00 X 0 0 0 DAVID G HILL MD DIRECTOR 2.00 X 0 0 0 MARK C JOHNSON CFA MBA DIRECTOR 2.00 X 0 0 0 WENDY LAWSON MPH RRT DIRECTOR 2.00 X 0 0 0 COLLEEN M MCINTOSH JD LLM DIRECTOR 2.00 X 0 0 0 SEAN R MULDOON MD MPH FCCP DIRECTOR 2.00 X 0 0 0 JOE OCHIPINTI DIRECTOR 2.00 X 0 0 0 JONATHON K ROSEN BA DIRECTOR 2.00 X 0 0 0 LAURIE SHELBY DIRECTOR 2.00 X 0 0 0 STERLING QL YEE MBA DIRECTOR 2.00 X 0 0 0 HAROLD WIMMER PRESIDENT & CEO 40.00 X 589964 0 65363 LAURA SCOTT CHIEF FINANCIAL OFFICER 40.00 X 297372 0 30977 JEFF SEYLER CHIEF FIELD OFFICER 40.00 X 281280 0 44499 SUE SWAN CHIEF DEVELOPMENT OFFICER 40.00 X 272073 0 51998 JULIA FITZGERALD CHIEF MARKETING OFFICER 40.00 X 281280 0 37567 DEBORAH BROWN CHIEF MISSION OFFICER 40.00 X 272073 0 40914 SARAH KRIKORIAN CHIEF HUMAN RESOURCES OFFICER 40.00 X 260000 0 37527 NEIL BALLENTINE CHIEF TECHNOLOGY OFFICER 40.00 X 225372 0 36151 LEA GUTIERREZ CHIEF DIVERSITY OFFICER 40.00 X 202042 0 20743 JOENELL HENRY-TANNER CHIEF OF STAFF, SVP GOVERNANCE 40.00 X 207841 0 11422 PAUL BILLINGS NATIONAL SENIOR VP, PUBLIC POLICY 40.00 X 231142 0 29119 ALLISON HICKEY EXECUTIVE VP, MOUNTAIN PACIFIC & CA 40.00 X 218223 0 28549 SUSAN RAPPAPORT NATIONAL VP, RESEARCH 40.00 X 202359 0 36047 EMILY MURPHY DIVISION SENIOR VP, DEVELOPMENT 40.00 X 182607 0 30863 MARIA VANEGAS-ZEA NATIONAL AVP, HUMAN RESOURCES 40.00 X 165285 0 39041 3888913 0 540780 80 0 1 0 PRODUCTION SOLUTIONS 1953 GALLOWS RD SUITE 500 VIENNA VA 22182 MARKETING 4460810 AD COUNCIL 815 SECOND AVENUE 9TH FLOOR NEW YORK NY 10017 PUBLIC SERVICE ADVERTISING 2981070 RR DONNELLEY 35 W WACKER DRIVE CHICAGO IL 60601 MARKETING 2854643 INNOVAIRREBRICKMILL MARKETING SERVICES 2 EXECUTIVE CAMPUS SUITE 200 CHERRY HILL NJ 08002 MARKETING 2261054 RESCUE AGENCY PUBLIC BENEFIT LLC 2437 MORENA BLVD SAN DIEGO CA 92110 MARKETING 1219257 73 13603221 30465862 56240588 87360 100309671 PROGRAM PARTICIPANT FEE 541900 1349983 1349983 PROGRAM SERVICE CONTRACTS 541900 888559 888559 MEMBERSHIP DUES 541900 81463 81463 2320005 4570324 4570324 1763749 1763749 178576 0 178576 178576 178576 9345721 13368 10661484 22606 -1315763 -9238 -1325001 -1325001 1603124 13603221 3022304 -1419180 -1419180 RESEARCH GRANT SERVICE FEE 541900 1727266 1727266 463652 463652 2190918 108589062 4510923 0 3768468 X 13632659 13632659 3362632 2959112 100885 302635 33805780 28836722 888125 4080933 2777646 2372001 71104 334541 3791775 3242886 97887 451002 2599546 2225550 67501 306495 378000 378000 84840 84840 30555502 29557449 348058 649995 1451874 1119965 3630 328279 1173693 950615 57307 165771 2949868 2309895 232504 407469 1165585 1048019 43095 74471 165118 127740 27665 9713 387983 387983 487554 369500 40865 77189 DIRECT MAIL 12789430 7801553 639472 4348405 MISCELLANEOUS 1149706 496126 468787 184793 PRINTING 131642 98431 1201 32010 POSTAGE & SHIPPING 120235 88267 2978 28990 112961068 97236490 3563887 12160691 X 12789430 7801553 639472 4348405 144821 240090 27213680 17483806 17309277 18912971 10687 637 121536 90095 2298896 2144445 21386226 10692463 11037770 10693763 120122477 129437208 36789972 42356524 215049116 221359539 12591730 13316160 12257372 13598538 11447314 7612007 1781745 0 11307430 12434203 49385591 46960908 X 121282464 126807362 44381061 47591269 165663525 174398631 215049116 221359539 X -4372006 9141175 3965937 X X 0 1 X 1 1 1 X 93429565 89851926 83540236 112291164 100309671 479422562 93429565 89851926 83540236 112291164 100309671 479422562 5016531 474406031 4659481 4822544 4656339 8400917 6512649 29051930 5053253 452244 311677 5817174 514291666 32143361 0.92240 0.90200 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2018 AMOUNT: $ 808,279. 2019 AMOUNT: $ 452,244. 2020 AMOUNT: $ 311,677. RESEARCH GRANT SERVICE FEE - 2018 AMOUNT: $ 408,500. TRUST INCOME - 2018 AMOUNT: $ 1,706,953. PROGRAM PARTICIPANT FEES - 2018 AMOUNT: $ 2,129,521. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 1 17899 1 44080 1 875 1 32175 1 672937 1 9262 0 777228 0 PART II-B, LINE 1: THE AMERICAN LUNG ASSOCIATION VOLUNTEERS AND STAFF ENGAGE IN A WIDE RANGE OF ADVOCACY ACTIVITIES TO FURTHER OUR MISSION TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. OUR WORK INCLUDES EFFORTS TO EDUCATE ELECTED OFFICIALS, THEIR STAFF AND THE PUBLIC ON LUNG HEALTH ISSUES AND ACCESS TO HEALTHCARE. WE ADVOCATE FOR CLEAN, HEALTHY AIR TO REDUCE THE HEALTH IMPACTS OF AIR POLLUTION AND CURB CLIMATE CHANGE. WE FOCUS ON SUPPORTING THE IMPLEMENTATION AND STRENGTHENING OF THE NATION'S CLEAN AIR LAWS. WE STRONGLY SUPPORT THE PUBLIC HEALTH INFRASTRUCTURE AND LUNG HEALTH RESEARCH FUNDING INCLUDING FUNDING FOR LUNG CANCER, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), ASTHMA, TUBERCULOSIS AND OTHER LUNG DISEASES. FURTHERMORE, THE AMERICAN LUNG ASSOCIATION VOLUNTEERS AND STAFF ACTIVELY ADVOCATE AT THE NATIONAL, STATE AND LOCAL LEVELS FOR TOBACCO CONTROL LAWS, INCLUDING EFFORTS TO REGULATE TOBACCO PRODUCTS INCLUDING E-CIGARETTES, PROMOTE TOBACCO CESSATION AND ELIMINATE EXPOSURE TO SECONDHAND SMOKE. 7970231 1005405 648658 519731 9104563 9016928 5300 -952335 99662 7970231 8600852 5000 1326442 915366 9016928 8779996 6100 -40790 144454 8600852 7773457 1003500 256966 253927 8779996 1.00000 0 0 2582203 2582203 14536948 6634117 7902831 455278 336108 119170 3811797 3722238 89559 10693763 BENEFICIAL INTEREST IN PERPETUAL TRUSTS 36725226 AMOUNTS HELD ON BEHALF OF OTHERS 1093269 REFUNDABLE DEPOSITS 251198 RIGHT-OF-USE-ASSETS 4286831 42356524 AMOUNTS HELD ON BEHALF OF OTHERS 1093269 ANNUITY FUND INVESTMENTS 824311 LEASE LIABILITIES 4671453 OTHER LIABILITIES 18988 PENSION & LIFE INSURANCE BENEFITS 5826182 12434203 X 189921453 9141175 68310119 3965937 81417231 108504222 84840 84840 108589062 181186347 68310119 68310119 112876228 84840 84840 112961068 PART V, LINE 4: PROCEEDS EARNED FROM THE CORPUS OF THESE NUMEROUS ENDOWMENT FUNDS MAY BE EXPENDED FOR RESEARCH, RESEARCH FELLOWSHIPS, LUNG-HEALTH EDUCATION, CONTINUING MEDICAL EDUCATION LECTURES, SCHOLARSHIPS, PATIENT ASSISTANCE, ADVOCACY, TOBACCO CESSATION ASSISTANCE, AND GENERAL OPERATIONS IN ACCORDANCE WITH DONOR STIPULATIONS. PART X, LINE 2: THE ASSOCIATION IS DESIGNATED AS A NON-PROFIT ORGANIZATION AND IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. IT HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION. THEREFORE, CHARITABLE CONTRIBUTIONS ARE TAX DEDUCTIBLE. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN FAIR VALUE OF BENEFICIAL INTEREST IN TRUSTS 1,456,320. CHANGE IN VALUE OF SPLIT-INTEREST TRUSTS -2,416. CHANGE IN VALUE OF EQUITY METHOD INVESTMENTS 2,554,103. PENSION AND POSTRETIREMENT PLAN CHANGES -42,070. X X X 1 NNE MARKETING 1666 MASSACHUSETTS AVE SUITE 14 LEXINGTON MA 02420 DIRECT MARKETING 0 15408376 378000 15030376 15408376 378000 15030376 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC FIGHT FOR AIR CLIMB 6368037 6368037 59061 199682 30248 14387 509904 LUNG FORCE WALKS 2279213 2279213 7269 70212 16410 13052 246370 42 6559095 4955971 1603124 101516 421706 446569 32607 853311 15206345 13603221 1603124 167846 691600 493227 60046 1609585 3022304 -1419180 SCHEDULE G, PART I, LINE 2B, COLUMN (V) THE AMERICAN LUNG ASSOCIATION ACQUIRES CONTRIBUTIONS FROM DIRECT MAIL AND TELEMARKETING SERVICES. IN ORDER TO MANAGE THESE ACTIVITIES, THE AMERICAN LUNG ASSOCIATION CONTRACTS WITH PROFESSIONAL FUNDRAISERS TO DEVELOP FUNDRAISING STRATEGIES ON THESE INITIATIVES. 1 AMERICAN THORACIC SOCIETY INC 25 BROADWAY 4TH FL NEW YORK CITY NY 10004 061548706 501(C)(3) 33334 0 RESEARCH ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA PO BOX 3308 TUCSON AZ 85722 742652689 STATE OF AZ 358487 0 RESEARCH BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 770303411 741613878 501(C)(3) 494622 0 RESEARCH BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVE BOSTON MA 02115 042774441 501(C)(3) 150000 0 RESEARCH BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS ST BOSTON MA 02115 042312909 501(C)(3) 547500 0 RESEARCH DUKE UNIVERSITY BOX 104132 DURHAM NC 27708 560532129 501(C)(3) 585462 0 RESEARCH HEALTH RESEARCH INC 150 BROADWAY STE 280 MENANDS NY 12204 141402155 501(C)(3) 150000 0 RESEARCH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE BOX 3500 NEW YORK CITY NY 100296574 136171197 501(C)(3) 845000 0 RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICH RD N4 327-B BALTIMORE MD 21211 520595110 501(C)(3) 1072500 0 RESEARCH KANSAS STATE UNIVERSITY 103 FAIRCHILD HALL 1601 VATTIER ST MANHATTAN KS 66506 480771751 STATE OF KS 200000 0 RESEARCH LOVELACE RESPIRATORY RESEARCH INSTITUTE 2425 RIDGECREST DR ALBUQUERQUE NM 87108 850110669 501(C)(3) 200000 0 RESEARCH MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT ST BOSTON MA 02114 041564655 501(C)(3) 400000 0 RESEARCH MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 200 FIRST ST SW ROCHESTER MN 55905 411506440 501(C)(3) 100000 0 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVE NEW YORK NY 100656007 131924236 501(C)(3) 200000 0 RESEARCH NATIONAL JEWISH MEDICAL AND RESEARCH CENTER 1400 JACKSON ST DENVER CO 80206 742044647 501(C)(3) 271842 0 RESEARCH NEMOURS CHILDREN CLINIC 10140 CENTURION PARKWAY NORTH JACKSONVILLE FL 32256 590634433 501(C)(3) 203187 0 RESEARCH NORTHWESTERN UNIVERSITY 619 CLARK ST EVANSTON IL 60208 362167817 501(C)(3) 1056242 0 RESEARCH OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK RD PORTLAND OR 97239 931176109 STATE OF OR 200000 0 RESEARCH PURDUE UNIVERSITY 2550 NORTHWESTERN AVE STE 1100 WEST LAFAYETTE IN 479061332 356002041 STATE OF IN 150000 0 RESEARCH RUTGERS BIOMEDICAL AND HEALTH SCIENCES 33 KNIGHTSBRIDGE RD PISCATAWAY NJ 08854 462354111 STATE OF NJ 200000 0 RESEARCH SEATTLE BIOMEDICAL RESEARCH INSTITUTE 307 WESTLAKE AVE SEATTLE WA 98109 911452438 501(C)(3) 148447 0 RESEARCH TEMPLE UNIVERSITY 1852 N 10TH ST PHILADELPHIA PA 19122 231365971 501(C)(3) 305662 0 RESEARCH TEXAS BIOMEDICAL RESEARCH INSTITUTE 8715 W MILITARY DR SAN ANTONIO TX 78227 741109630 501(C)(3) 500000 0 RESEARCH TEXAS TECH UNIVERSITY BOX 41092 LUBBOCK TX 794091092 756002622 STATE OF TX 200000 0 RESEARCH THE MEDICAL COLLEGE OF WISCONSIN INC 8701 WATERTOWN PLANK RD MILLWAUKEE WI 53226 390806261 501(C)(3) 100000 0 RESEARCH THE OHIO STATE UNIVERSITY 901 WOODY HAYES DR COLUMBUS OH 43210 316025986 STATE OF OH 297500 0 RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE 120 TEORY STE 200 IRVINE CA 926971050 952226406 STATE OF CA 200000 0 RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO 6200 GREENWICH DR SAN DIEGO CA 92122 237064656 STATE OF CA 200000 0 RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM ST SAN FRANCISCO CA 94143 946036493 STATE OF CA 373132 0 RESEARCH THE REGENTS OF THE UNIVERSITY OF MICHIGAN 5082 WOLVERINE TOWER 3003 S STATE ST ANNARBOR MI 48109 386006309 STATE OF MI 622497 0 RESEARCH THE ROCKEFELLER UNIVERSITY 1230 YORK AVE NEW YORK CITY NY 10065 131624158 501(C)(3) 200000 0 RESEARCH THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 615 WEST 131ST ST NEW YORK CITY NY 10027 135598093 501(C)(3) 380107 0 RESEARCH THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL PO BOX 402420 ATLANTA GA 303842420 566001393 501(C)(3) 150000 0 RESEARCH THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON 301 UNIVERSITY BLVD GALVESTON TX 775551166 746000949 STATE OF TX 100000 0 RESEARCH THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY 3601 SPRUCE ST PHILADELPHIA PA 19104 236434390 501(C)(3) 200000 0 RESEARCH TRUSTEES OF BOSTON UNIVERSITY 881 COMMONWEALTH AVE BOSTON MA 02215 042103547 501(C)(3) 200000 0 RESEARCH TRUSTEES OF THE UNIVERSTITY OF PENNSYLVANIA 3451 WALNUT ST PHILADELPHIA PA 19104 231352685 501(C)(3) 200000 0 RESEARCH UNIVERSITY OF ALABAMA AT BIRMINGHAM UNIVERSITY STATION BIRMINGHAM AL 35294 636005396 501(C)(3) 303847 0 RESEARCH UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 109 KINKEAD HALL LEXINGTON KY 405060057 616033693 501(C)(3) 150000 0 RESEARCH UNIVERSITY OF MARYLAND-COLLEGE PARK 7809 REGENTS DR 3112 LEE BUILDING COLLEGE PARK MD 207425141 526002033 STATE OF MD 150000 0 RESEARCH UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL 333 SOUTH ST STE 450 SHREWSBURY MA 015454176 043167352 STATE OF MA 200000 0 RESEARCH UNIVERSITY OF PITTSBURGH 371220 500 ROSS ST 154-0455 PITTSBURGH PA 152620001 250965591 501(C)(3) 200000 0 RESEARCH UNIVERSITY OF VERMONT 85 SOUTH PROSPECT ST BURLINGTON VT 05405 030179440 501(C)(3) 291667 0 RESEARCH UNIVERSITY OF WASHINGTON 325 9TH AVE BOX 359931 SEATTLE WA 98104 916001537 STATE OF WA 100000 0 RESEARCH UNIVERSITY OF KANSAS MEDICAL CENTER 2385 IRVING HILL RD LAWRENCE KS 66045 480680117 501(C)(3) 372397 0 RESEARCH WASHINGTON UNIVERSITY 700 ROSEDALE AVE CAMPUS BOX 1034 ST LOUIS MO 631121408 430653611 501(C)(3) 47500 0 RESEARCH WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY PO BOX 22371 NEW YORK NY 100872371 131623978 501(C)(3) 150000 0 RESEARCH YALE UNIVERSITY 2 WHITNEY AVE 6TH FLOOR NEW HAVEN CT 06510 060646973 501(C)(3) 250000 0 RESEARCH RETURNED FUNDS & CANCELLED PAYMENTS - VARIOUS UNIVERSITIES 55 W WACKER DR CHICAGO IL 60601 131632524 501(C)(3) -378273 0 RESEARCH 48 0 PART I, LINE 2: AWARD RECIPIENTS ARE REQUIRED TO SUBMIT A RENEWAL APPLICATION AFTER THEIR FIRST YEAR OF FUNDING. RENEWAL APPLICATIONS ARE THEN REVIEWED BY OUR RESEARCH COMMITTEE CHAIRS FOR APPROVAL OF SECOND YEAR FUNDING. AT THE TIME OF TERMINATION (AFTER THE SECOND YEAR OF FUNDING), AWARD RECIPIENTS ARE REQUIRED TO SUBMIT A SUMMARY OF THEIR ACTIVITIES, COPIES OF PRESENTATIONS AND/OR PUBLICATIONS, AND A CASH DISBURSEMENT REPORT FOR THE ENTIRE GRANT TIME. X X X X X X 0 1 0 0 0 0 0 0 0 HAROLD WIMMER PRESIDENT & CEO 539964 0 50000 0 0 0 34145 0 31218 0 655327 0 0 0 LAURA SCOTT CHIEF FINANCIAL OFFICER 273372 0 24000 0 0 0 29062 0 1915 0 328349 0 0 0 JEFF SEYLER CHIEF FIELD OFFICER 263280 0 18000 0 0 0 33596 0 10903 0 325779 0 0 0 SUE SWAN CHIEF DEVELOPMENT OFFICER 257073 0 15000 0 0 0 30736 0 21262 0 324071 0 0 0 JULIA FITZGERALD CHIEF MARKETING OFFICER 263280 0 18000 0 0 0 16192 0 21375 0 318847 0 0 0 DEBORAH BROWN CHIEF MISSION OFFICER 257073 0 15000 0 0 0 29034 0 11880 0 312987 0 0 0 SARAH KRIKORIAN CHIEF HUMAN RESOURCES OFFICER 245000 0 15000 0 0 0 16866 0 20661 0 297527 0 0 0 NEIL BALLENTINE CHIEF TECHNOLOGY OFFICER 210372 0 15000 0 0 0 22257 0 13894 0 261523 0 0 0 PAUL BILLINGS NATIONAL SENIOR VP, PUBLIC POLICY 220263 0 10879 0 0 0 27018 0 2101 0 260261 0 0 0 ALLISON HICKEY EXECUTIVE VP, MOUNTAIN PACIFIC & CA 207971 0 10252 0 0 0 17081 0 11468 0 246772 0 0 0 SUSAN RAPPAPORT NATIONAL VP, RESEARCH 198412 0 3947 0 0 0 23542 0 12505 0 238406 0 0 0 LEA GUTIERREZ CHIEF DIVERSITY OFFICER 192042 0 10000 0 0 0 9571 0 11172 0 222785 0 0 0 JOENELL HENRY-TANNER CHIEF OF STAFF, SVP GOVERNANCE 197841 0 10000 0 0 0 9891 0 1531 0 219263 0 0 0 EMILY MURPHY DIVISION SENIOR VP, DEVELOPMENT 173988 0 8619 0 0 0 17587 0 13276 0 213470 0 0 0 MARIA VANEGAS-ZEA NATIONAL AVP, HUMAN RESOURCES 155373 0 9912 0 0 0 19260 0 19781 0 204326 0 0 0 PART I, LINE 4B HAROLD WIMMER RECEIVED $33,045 FROM A 457(F) PLAN. X SUPPLIES 50 87360 FMV 0 1 0 FORM 990, PART VI, SECTION A, LINE 1A EXECUTIVE COMMITTEE: THE EXECUTIVE COMMITTEE SHALL ACT IN PLACE OF AND WITH THE FULL AUTHORITY OF THE BOARD OF DIRECTORS WHEN THE BOARD OF DIRECTORS IS NOT IN SESSION, SUBJECT TO THE BOARD'S POWER TO AMEND OR CHANGE THOSE ACTIONS WHICH HAVE NOT BEEN IMPLEMENTED PRIOR TO THE BOARD MEETING OR MEETINGS FOLLOWING THE EXECUTIVE MEETING AT WHICH SUCH ACTION WAS TAKEN. THE BOARD OF DIRECTORS HAS THE POWER TO AUTHORIZE AND DELEGATE TO THE EXECUTIVE COMMITTEE TO THE EXTENT PERMITTED BY THE ASSOCIATION'S BYLAWS AND APPLICABLE LAW. THE EXECUTIVE COMMITTEE SHALL NOT HAVE THE AUTHORITY TO APPOINT OFFICERS EXCEPT ON AN INTERIM BASIS TO FILL A VACANCY, ENTER INTO OR AMEND CONTRACTS WITH OFFICERS, AMEND THE POLICIES MANUAL, OR BORROW MONEY IN EXCESS OF THE AMOUNTS EXPRESSLY AUTHORIZED BY THE BOARD. THE EXECUTIVE COMMITTEE SHALL HAVE NO AUTHORITY TO AMEND THE ARTICLES OF INCORPORATION, ADOPT A PLAN OF MERGER OR CONSOLIDATION, AUTHORIZE THE SALE OR OTHER DISPOSITION OF ALL OR SUBSTANTAILLY ALL OF THE PROPERTY AND ASSETS OF THE ASSOCIATION, AUTHORIZE THE VOLUNTARY DISSOLUTION OF THE ASSOCIATION OR REVOCATION OF SUCH DISSOLUTION, OR AMEND THE BYLAWS OF THE ASSOCIATION. THE EXECUTIVE COMMITTEE MAY ESTABLISH A LEADERSHIP SUBCOMMITTEE CONSISTING OF THE CHAIR, VICE-CHAIR, AND PAST-CHAIR, WHICH SHALL SERVE AS THE EXECUTIVE COMMITTEE'S LIAISON TO THE PRESIDENT AND CEO. THE GOVERNANCE COMMITTEE, TAKING INTO ACCOUNT GEOGRAPHY, EXPERTISE, RACE, ETHNICITY, GENDER, AGE AND OTHER DIVERSITY FACTORS, SHALL PRESENT ANNUALLY TO THE BOARD OF DIRECTORS ITS RECOMMENDED NOMINEES FOR MEMBERS OF THE BOARD OF DIRECTORS, MEMBERS OF THE GOVERNANCE COMMITTEE AND OFFICERS (OTHER THAN THE PRESIDENT AND CHIEF EXECUTIVE OFFICER) OF THE ASSOCIATION (INCLUDING A RECOMMENDATION WHERE APPROPRIATE, FOR THE DESIGNATION OF THE VICE-CHAIR AS CHAIR-ELECT). OTHER NOMINATIONS MAY NOT BE MADE AT THE MEETING OF THE BOARD OF DIRECTORS FROM THE FLOOR. FORM 990, PART VI, SECTION B, LINE 11B AMERICAN LUNG ASSOCIATION HAS ESTABLISHED THE FOLLOWING REVIEW PROCESS TO ENSURE THAT THE INFORMATION REPORTED IS COMPLETE AND ACCURATE. FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND REVIEWED BY THE CFO. PRIOR TO ELECTRONIC SUBMISSION, IT IS REVIEWED BY THE ORGANIZATION'S DELEGATED RESPONSIBLE BODY, THE AUDIT AND RISK OVERSIGHT COMMITTEE, FOR APPROVAL. AFTER APPROVAL BY THE AROC COMMITTEE, THE MEMBERS OF THE GOVERNING BODY REVIEW THE FORM PRIOR TO SUBMISSION. ALL COMMENTS ARE DOCUMENTED, ADDRESSED AND FINALIZED BEFORE SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C ALA CURRENTLY HAS IN PLACE A CONFLICT OF INTEREST POLICY WHICH IT MONITORS AND ENFORCES ANNUALLY AND HAS A STANDING GOVERNANCE COMMITTEE THAT OVERSEES ITS EXECUTION. THE ORGANIZATION CURRENTLY MANDATES THAT ALL MEMBERS OF THE GOVERNING BODY, COMMITTEE MEMBERS AND ALL STAFF ANNUALLY SIGN A CONFLICT OF INTEREST POLICY AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS THAT MAY EXIST. THE SIGNED CONFLICT OF INTEREST POLICY STATEMENTS ARE SUBMITTED TO THE GOVERNANCE COMMITTEE. THESE STATEMENTS ARE REVIEWED FOR POTENTIAL OR ACTUAL CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15 THE AMERICAN LUNG ASSOCIATION HAS ESTABLISHED A COMPENSATION POLICY FOR ITS LEADERSHIP COMMITTEE TO FOLLOW IN ESTABLISHING THE COMPENSATION FOR ITS CFO, TOP MANAGEMENT OFFICIAL, OTHER OFFICERS OR KEY EMPLOYEES. THE POLICY MANDATES THAT EXECUTIVE COMPENSATION BE PERIODICALLY REVIEWED BY THE COMMITTEE AND THAT THE COMMITTEE SHOULD BE FREE OF CONFLICTS OF INTEREST. IN ADDITION, THE APPROVING COMMITTEE NEEDS TO REVIEW APPROPRIATE AND ADEQUATE DATA TO DETERMINE THE REASONABLENESS OF THE COMPENSATION BEING CONSIDERED. THE COMMITTEE MAY USE A VARIETY OF INFORMATION AND STUDIES THAT ARE AVAILABLE TO DETERMINE THAT THE APPROPRIATE LEVEL OF COMPENSATION IS BEING PAID TO ITS EXECUTIVES. THE COMMITTEE'S DECISION ON THE AMOUNT OF COMPENSATION PAID IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT AND DOCUMENTS THE DATE OF THE DECISION, THE MEMBERS PRESENT DURING THE MEETING AND THOSE WHO VOTED ON IT. THE DETAILS OF THE TRANSACTION THAT WAS APPROVED AND THE COMPARABILITY DATA USED AND RELIED UPON TO MAKE THE DECISION. ALA CONDUCTS PERIODIC COMPENSATION REVIEW FOR THE CEO AS WELL AS OTHER OFFICERS AND KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE THREE MOST RECENT YEARS OF FORM 990 AND ANNUAL REPORTS ARE AVAILABLE ON AMERICAN LUNG ASSOCIATION'S WEBSITE, WWW.LUNG.ORG. GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE TO THE PUBLIC UPON REQUEST. OUR WEBSITE ALSO PROVIDES THE NAMES OF OUR BOARD OF DIRECTORS AND OUR ETHICS POLICY. FORM 990, PART IX, LINE 11G PROGRAM CONSULTING: PROGRAM SERVICE EXPENSES 21,793,898. TOTAL EXPENSES 21,793,898. OTHER FEES: PROGRAM SERVICE EXPENSES 7,763,551. MANAGEMENT AND GENERAL EXPENSES 348,058. FUNDRAISING EXPENSES 649,995. TOTAL EXPENSES 8,761,604. FORM 990, PART XI, LINE 9: CHANGE IN FAIR VALUE OF BENEFICIAL INTEREST IN TRUSTS 1,456,320. CHANGE IN VALUE OF SPLIT-INTEREST TRUSTS -2,416. CHANGE IN VALUE OF EQUITY METHOD INVESTMENTS 2,554,103. PENSION AND RETIREMENT PLAN CHANGES -42,070. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.